Aelis Farma, a biopharmaceutical company developing treatments for brain and peripheral disorders, has secured a €458,000 ($0.5M) grant. This non-dilutive funding, awarded through the France 2030 regional program in Nouvelle-Aquitaine, will support the company's research and development efforts.
Amount: $458.0K
